Asthma
Asthma is a chronic respiratory condition that causes inflammation and narrowing of the airways, leading to difficulty in breathing, wheezing, and coughing, especially during physical activity or at night.
Asthma Treatment: AMG 691 Study
We are testing a new medication called AMG 691 in healthy individuals and those with mild-to-moderate asthma. The goal is to see how it compares to a placebo in managing asthma symptoms.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Emmaues
Phase 1 Unit
Mechelen, Belgium
Sponsor: Amgen Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.